Public research preview
Josh Gottheimer, Representative disclosure: AbbVie Inc. Common Stock (ABBV)
Disclosed a buy transaction in AbbVie Inc. Common Stock (ABBV). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 17 Apr 2022, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 40 days
Timeline
Transaction date
8 Mar 2022
Public disclosure
17 Apr 2022
Now
Tracked today
Filing delay: 40 days
Price movement
Partial coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Missing Yahoo Finance daily close for disclosure date 2022-04-17.
Most of the move happened before this disclosure became public: the stock peaked +18.9% above the transaction-date close and has since retraced -6.4% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.
Stock path
ABBV from pre-transaction context through latest close.
Bought
8 Mar 2022 · 126.142 USD · Not public yet
System decision
Would have bought · Discount entry — The strategy would have bought this signal, but the entry window has closed. Simulated entry on 18 Apr 2022 at 137.769 USD. Since entry: +61.9%. Planned exit on 16 May 2022 after 20 trading days.
- Not public yet
- Buy window
- Window closed
- System buy
- Planned exit
- Fallback transaction price
- —
- Fallback disclosure price
- —
- Fallback latest price
- —
- Pre-disclosure move
- —
- Post-disclosure move
- —
- Market-adjusted move
- —
- 1w since disclosure
- —
- 1m since disclosure
- —
- 3m since disclosure
- —
- Pre-disclosure peak run-up
- +18.9%
- Retrace from peak
- -6.4%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is currently treated as 0% because market-price coverage is unavailable.
Cautions
- Missing Yahoo Finance daily close for disclosure date 2022-04-17.
- Copy Window is using a transaction-price fallback until coverage improves.
- Price coverage is partial; accepted for official-source intake before market data enrichment.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 17 Apr 2022, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%